ID   OMC-3
AC   CVCL_3354
SY   OMC3; Osaka Medical College-3
DR   CLO; CLO_0051448
DR   BioSample; SAMN03472226
DR   Cosmic; 1152555
DR   RCB; RCB0755
DR   Wikidata; Q54932034
RX   DOI=10.1267/ahc.26.515;
RX   PubMed=2010102;
CC   Population: Japanese.
CC   Doubling time: 98 hours (Note=At 27th passage) (PubMed=2010102).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): RCB=RCB0755
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 9,11
ST   D5S818: 13
ST   D7S820: 8
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
RX   DOI=10.1267/ahc.26.515;
RA   Tsuchida K., Okamoto Y., Yamada T., Ueda M., Iijima J., Shiina Y.,
RA   Hirano H., Rokukawa C., Kasama T., Taki T., Handa S., Ueki M.,
RA   Adachi K.;
RT   "Discrimination of metastatic cells from mesothelial cells in effusion
RT   cytology by monoclonal antibody AD117m directed against
RT   lactotetraosylceramide.";
RL   Acta Histochem. Cytochem. 26:515-530(1993).
//
RX   PubMed=2010102; DOI=10.1016/0090-8258(91)90102-B;
RA   Yamada T., Ueda M., Otsuki Y., Ueki M., Sugimoto O.;
RT   "Establishment and characterization of a cell line (OMC-3) originating
RT   from a human mucinous cystadenocarcinoma of the ovary.";
RL   Gynecol. Oncol. 40:118-128(1991).
//